Location History:
- Salt Lake City, UT (US) (2010 - 2015)
- Lawrence, KS (US) (2015)
- Phoenix, AZ (US) (2015 - 2017)
- Boston, MA (US) (2023)
Company Filing History:
4 out of 547 
2 out of 3,539 
2 out of 1,271 
Years Active: 2010-2024
Title: The Innovations of Warren S. Weiner: A Pioneer in Selective Dopamine Receptor Agonists
Introduction
Warren S. Weiner is a prominent inventor based in Salt Lake City, Utah, recognized for his groundbreaking contributions to the field of pharmacology. With a notable portfolio comprising 10 patents, Weiner has made significant advancements, particularly in the development of selective dopamine receptor agonists, which have vast potential in treating various neurological disorders.
Latest Patents
Weiner's latest patents focus on innovative compounds related to selective D3 dopamine receptor agonists and their therapeutic applications. Among these patents, the disclosure of a compound of Formula I or a pharmaceutically acceptable salt highlights essential methods for treating a multitude of conditions. These conditions include Parkinson's disease, related syndromes, dyskinesia, and neurodegenerative disorders such as Alzheimer's disease and Huntington's disease. Furthermore, the patents detail methods for addressing psychological conditions including bipolar disorder, depression, schizophrenia, and substance use disorders. The advanced compounds, along with pharmaceutically acceptable carriers, signify a major step forward in the medical field, offering hope for many patients suffering from these debilitating conditions.
Career Highlights
Weiner's career is marked by his affiliation with reputable institutions, including the University of Kansas, where his research has contributed to significant advancements in medical science. His extensive work in the development of dopamine receptor agonists has earned him recognition within the scientific community and among his peers.
Collaborations
Throughout his career, Weiner has collaborated with notable colleagues, including Mark B. Anderson and Rachel M. Slade. These partnerships have facilitated the pursuit of innovative solutions to complex medical challenges, further establishing Weiner's reputation as a leading inventor in his field.
Conclusion
Warren S. Weiner's contributions to the field of medicine not only showcase his innovative spirit but also reflect his commitment to improving patient outcomes through advanced therapeutic methods. With a strong foundation in research and collaboration, Weiner continues to be a pivotal figure in the development of treatments for various neurological and psychological disorders, paving the way for future advancements in pharmacology.